PortfoliosLab logoPortfoliosLab logo
ZIVO vs. HACBY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ZIVO vs. HACBY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ZIVO Bioscience, Inc. (ZIVO) and Hachijuni Bank Ltd ADR (HACBY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ZIVO achieves a -54.02% return, which is significantly lower than HACBY's 37.17% return. Over the past 10 years, ZIVO has outperformed HACBY with an annualized return of 28.41%, while HACBY has yielded a comparatively lower -3.64% annualized return.


ZIVO

1D
0.00%
1M
-23.81%
6M
-61.90%
YTD
-54.02%
1Y
-59.88%
3Y*
-30.66%
5Y*
-28.23%
10Y*
28.41%
ALL TIME*
11.11%

HACBY

1D
0.00%
1M
11.21%
6M
37.17%
YTD
37.17%
1Y
76.03%
3Y*
-14.13%
5Y*
-0.21%
10Y*
-3.64%
ALL TIME*
-5.47%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$9.08$360.93$286.45
$4.68K$3.81K$4.67K

ZIVO vs. HACBY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ZIVO
ZIVO Bioscience, Inc.
-54.02%-59.53%1,691.67%-92.00%-12.89%1,813.33%-11.76%30.77%44.44%-5.26%
HACBY
Hachijuni Bank Ltd ADR
37.17%91.80%-77.26%32.97%24.57%-3.28%-22.69%7.06%-29.46%-0.06%

Correlation

The correlation between ZIVO and HACBY is -0.06, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

-0.06

Correlation (3Y)
Balances recent behavior with more history.

-0.04

Correlation (5Y)
Shows whether the relationship held over a longer period.

-0.01

Correlation (10Y)
Provides a long-term view across more market conditions.

0.02

Correlation (All Time)
Calculated using the full available price history since Jan 4, 2016

0.01

Fundamentals

Market Cap

ZIVO:

$15.55M

HACBY:

$6.89B

EPS

ZIVO:

-$1.70

HACBY:

¥284.46

PS Ratio

ZIVO:

131.10

HACBY:

3.63

Total Revenue (TTM)

ZIVO:

$119.03K

HACBY:

¥299.73B

Gross Profit (TTM)

ZIVO:

$39.21K

HACBY:

¥244.80B

EBITDA (TTM)

ZIVO:

-$6.59M

HACBY:

¥80.85B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ZIVO vs. HACBY — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ZIVO
ZIVO Risk / Return Rank: 3333
Overall Rank
ZIVO Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
ZIVO Sortino Ratio Rank: 4747
Sortino Ratio Rank
ZIVO Omega Ratio Rank: 4949
Omega Ratio Rank
ZIVO Calmar Ratio Rank: 1919
Calmar Ratio Rank
ZIVO Martin Ratio Rank: 2020
Martin Ratio Rank

HACBY
HACBY Risk / Return Rank: 9494
Overall Rank
HACBY Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
HACBY Sortino Ratio Rank: 9494
Sortino Ratio Rank
HACBY Omega Ratio Rank: 9999
Omega Ratio Rank
HACBY Calmar Ratio Rank: 9595
Calmar Ratio Rank
HACBY Martin Ratio Rank: 9696
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ZIVO vs. HACBY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ZIVO Bioscience, Inc. (ZIVO) and Hachijuni Bank Ltd ADR (HACBY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ZIVOHACBYDifference
Sharpe ratioReturn per unit of total volatility

-1.93

Sortino ratioReturn per unit of downside risk

-2.68

Omega ratioGain probability vs. loss probability

1.08

2.29

-1.21

Calmar ratioReturn relative to maximum drawdown

-0.67

4.92

-5.59

Martin ratioReturn relative to average drawdown

-1.09

15.47

-16.55

ZIVO vs. HACBY - Sharpe Ratio Comparison

The current ZIVO Sharpe Ratio is -0.34, which is lower than the HACBY Sharpe Ratio of 1.59. The chart below compares the historical Sharpe Ratios of ZIVO and HACBY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ZIVO vs. HACBY - Drawdown Comparison

The maximum ZIVO drawdown since its inception was -98.52%, which is greater than HACBY's maximum drawdown of -85.63%. Use the drawdown chart below to compare losses from any high point for ZIVO and HACBY.


Loading charts...

Drawdown Indicators


ZIVOHACBYDifference

Max Drawdown

Largest peak-to-trough decline

-98.52%

-85.63%

-12.89%

Max Drawdown (1Y)

Largest decline over 1 year

-93.85%

-15.53%

-78.32%

Max Drawdown (3Y)

Largest decline over 3 years

-96.18%

-85.52%

-10.66%

Max Drawdown (5Y)

Largest decline over 5 years

-98.52%

-85.52%

-13.00%

Max Drawdown (10Y)

Largest decline over 10 years

-98.52%

-85.63%

-12.89%

Current Drawdown

Current decline from peak

-87.77%

-56.92%

-30.85%

Average Drawdown

Average peak-to-trough decline

-63.98%

-41.26%

-22.72%

Ulcer Index

Depth and duration of drawdowns from previous peaks

57.67%

4.93%

+52.74%

Volatility

ZIVO vs. HACBY - Volatility Comparison

ZIVO Bioscience, Inc. (ZIVO) has a higher volatility of 46.24% compared to Hachijuni Bank Ltd ADR (HACBY) at 10.62%. This indicates that ZIVO's price experiences larger fluctuations and is considered to be riskier than HACBY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ZIVOHACBYDifference

Volatility (1M)

Calculated over the trailing 1-month period

46.24%

10.62%

+35.62%

Volatility (6M)

Calculated over the trailing 6-month period

139.92%

21.74%

+118.18%

Volatility (1Y)

Calculated over the trailing 1-year period

185.49%

47.96%

+137.53%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

142.36%

64.45%

+77.91%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

1,082.66%

52.55%

+1,030.11%

Dividends

ZIVO vs. HACBY - Dividend Comparison

ZIVO has not paid dividends to shareholders, while HACBY's dividend yield for the trailing twelve months is around 0.85%.


PositionTTM2025202420232022202120202019201820172016
HACBY
Hachijuni Bank Ltd ADR
0.85%2.95%7.24%0.00%0.00%0.00%0.00%0.00%0.00%1.26%2.44%
ZIVO
ZIVO Bioscience, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

ZIVO vs. HACBY - Financials Comparison

This section allows you to compare key financial metrics between ZIVO Bioscience, Inc. and Hachijuni Bank Ltd ADR. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


ZIVO and HACBY have a correlation of -0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ZIVO has higher volatility (46.24%) compared to HACBY (10.62%). In terms of maximum drawdown, ZIVO dropped -98.52% vs HACBY's -85.63%.

HACBY currently has the higher Sharpe Ratio (1.59 vs -0.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ZIVO and HACBY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer